‘BD keeps close contact for collecting Covid-19 vaccine’

block
City Desk :
Health and Family Welfare Minister Zahid Maleque said Bangladesh is keeping close communication with those companies, which are at the final stage of Covid-19 vaccine development.
“Many countries are working frantically for Covid-19 vaccine development campaign… But nine companies are at final stage in the race of vaccine development. We are keeping constant communication with five companies to get effective vaccines at the quickest possible time,” he said.
Prime Minister Sheikh Hasina has given all necessary instructions to take all preparations including financial issue for collecting effective and safe vaccine soon after it is developed by a company in the world, the minister said this on Wednesday while speaking at the inaugural function of modernization and expanded programme of Dhaka Medical College Hospital (DMCH), an official press release said.
Bangladesh is successfully handling Covid-19 pandemic through taking prompt preventive measures to contain the spread of the deadly virus, he said, adding the government has been taking multiple measures to halt the outbreak of coronovirus in the country.
Director General of Directorate General of Health Services (DGHS) Prof Dr Abul Bashar Mohammad Khurshid Alam, Additional Secretary of Health Service Division Mahibur Rahman and senior officials of the health ministry, among others, were present at the function with DMCH Director Brig Gen AKM Nasir Uddin in the chair.
About the second wave of coronavirus, Maleque said many countries across the world including the USA and some European nations ignored the deadly virus and as a result they are facing a second wave of Covid-19.
“We are now aware enough of the second wave of the killer disease…. Bangladesh may face second wave of coronavirus. So, we have to be careful of the lethal virus,” he added.
The Health Ministry sources said many countries including China, the UK, the USA, Russia and India are in the final stage for vaccine development as they are performing phase-3 human trial of Covid-19 vaccine development.

block